Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 29, 2018 Filed Feb 13, 2019 17:23 UTC |
STANGER KENT WDirector
|
GiftCommon Stock, No Par Value | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0000856982-19-000010 · wf-form5_155007860090520.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,665 F4 · price: This is a gift. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:46 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 42,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0000856982-18-000064 · wf-form4_153367479990652.xml · derivative · entry 6 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:46 UTC |
STANGER KENT WDirector
|
Tax withholdingCommon Stock, No Par Value | 20,229 | $55.75 | $1,127,766.75 |
DisclosureSEC source: 0000856982-18-000064 · wf-form4_153367479990652.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,755 F4 · kind: Stock options were exercised in a swap transaction with the Company. 20,229 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:46 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 42,000 | $13.75 | $577,500.00 |
DisclosureSEC source: 0000856982-18-000064 · wf-form4_153367479990652.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Stock options were exercised in a swap transaction with the Company. 20,229 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 6,900 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · derivative · entry 10 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,900 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
SaleCommon Stock, No Par Value | 4,106 | $50.95 | $209,192.49 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · nonDerivative · entry 7 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,038 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.905 to $50.950, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
Exercise / conversionCommon Stock, No Par Value | 6,900 | $13.75 | $94,875.00 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · nonDerivative · entry 6 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,600 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · derivative · entry 9 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,900 Underlying: Common Stock · 1,600 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| June 22, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
SaleCommon Stock, No Par Value | 1,600 | $50.23 | $80,374.40 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · nonDerivative · entry 5 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,244 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.15 to $50.50, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 22, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
Exercise / conversionCommon Stock, No Par Value | 1,600 | $13.75 | $22,000.00 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · nonDerivative · entry 4 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,500 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · derivative · entry 8 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 1,500 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
SaleCommon Stock, No Par Value | 1,500 | $50.05 | $75,075.00 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · nonDerivative · entry 3 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,244 Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:12 UTC |
Miller Franklin JDirector
|
Exercise / conversionCommon Stock, No Par Value | 1,500 | $13.75 | $20,625.00 |
DisclosureSEC source: 0000856982-18-000058 · wf-form4_152996833765632.xml · nonDerivative · entry 2 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 19:24 UTC |
Wright JosephPresident, International
|
Exercise / conversionCommon Stock · Derivative | 10,072 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0000856982-18-000056 · wf-form4_152909067638094.xml · derivative · entry 6 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,072 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 19:24 UTC |
Wright JosephPresident, International
|
SaleCommon Stock, No Par Value | 10,072 | $49.53 | $498,846.02 |
DisclosureSEC source: 0000856982-18-000056 · wf-form4_152909067638094.xml · nonDerivative · entry 4 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.55 to $49.65, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 19:24 UTC |
Wright JosephPresident, International
|
Exercise / conversionCommon Stock, No Par Value | 10,072 | $13.75 | $138,490.00 |
DisclosureSEC source: 0000856982-18-000056 · wf-form4_152909067638094.xml · nonDerivative · entry 3 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 19:24 UTC |
Wright JosephPresident, International
|
Exercise / conversionCommon Stock · Derivative | 9,928 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0000856982-18-000056 · wf-form4_152909067638094.xml · derivative · entry 5 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,072 Underlying: Common Stock · 9,928 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 19:24 UTC |
Wright JosephPresident, International
|
SaleCommon Stock, No Par Value | 9,928 | $49.49 | $491,306.94 |
DisclosureSEC source: 0000856982-18-000056 · wf-form4_152909067638094.xml · nonDerivative · entry 2 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.45 to $49.58, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 19:24 UTC |
Wright JosephPresident, International
|
Exercise / conversionCommon Stock, No Par Value | 9,928 | $13.75 | $136,510.00 |
DisclosureSEC source: 0000856982-18-000056 · wf-form4_152909067638094.xml · nonDerivative · entry 1 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:19 UTC |
Karras Nolan E.Director
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000054 · wf-form4_152875554936019.xml · derivative · entry 9 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:11 UTC |
Gunderson Thomas J.Director
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000053 · wf-form4_152875505297666.xml · derivative · entry 2 Gunderson Thomas James · CIK 0001708144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:08 UTC |
STILLABOWER MICHAEL EDirector
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000052 · wf-form4_152875486909081.xml · derivative · entry 8 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:06 UTC |
ANDERSON A SCOTTDirector
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000051 · wf-form4_152875477906323.xml · derivative · entry 7 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:04 UTC |
LIU DAVID MING-TEHDirector
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000050 · wf-form4_152875466285311.xml · derivative · entry 3 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:03 UTC |
STANGER KENT WDirector
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000049 · wf-form4_152875457106419.xml · derivative · entry 10 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 06/07/2019. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 21:59 UTC |
Millner F. Ann Ed.D.Director
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000048 · wf-form4_152875435537820.xml · derivative · entry 5 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 21:58 UTC |
Miller Franklin JDirector
|
GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000047 · wf-form4_152875426533844.xml · derivative · entry 10 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 19:24 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008286 · edgar.xml · derivative · entry 3 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 19:24 UTC |
STILLABOWER MICHAEL EDirector
|
SaleCommon Stock, No Par Value | 12,050 | $50.50 | $608,525.00 |
DisclosureSEC source: 0001179110-18-008286 · edgar.xml · nonDerivative · entry 2 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,618 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.95 to $51.15, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 19:24 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $13.75 | $275,000.00 |
DisclosureSEC source: 0001179110-18-008286 · edgar.xml · nonDerivative · entry 1 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 20:40 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 14,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0000856982-18-000038 · wf-form4_152840401688702.xml · derivative · entry 3 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 20:40 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
SaleCommon Stock, No Par Value | 14,000 | $51.31 | $718,326.00 |
DisclosureSEC source: 0000856982-18-000038 · wf-form4_152840401688702.xml · nonDerivative · entry 2 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.20 to $51.45, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 20:40 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
Exercise / conversionCommon Stock, No Par Value | 14,000 | $13.75 | $192,500.00 |
DisclosureSEC source: 0000856982-18-000038 · wf-form4_152840401688702.xml · nonDerivative · entry 1 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:46 UTC |
Lampropoulos Fred P.Director · President & CEO
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 120,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008156 · edgar.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 8/11/2012. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:46 UTC |
Lampropoulos Fred P.Director · President & CEO
|
Tax withholdingCommon Stock, No Par Value | 70,878 | $52.00 | $3,685,656.00 |
DisclosureSEC source: 0001179110-18-008156 · edgar.xml · nonDerivative · entry 5 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,991 F2 · kind: Stock options were exercised in a swap transaction with the Company. 70,878 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:46 UTC |
Lampropoulos Fred P.Director · President & CEO
|
Exercise / conversionCommon Stock, No Par Value | 120,000 | $13.75 | $1,650,000.00 |
DisclosureSEC source: 0001179110-18-008156 · edgar.xml · nonDerivative · entry 4 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,190,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Stock options were exercised in a swap transaction with the Company. 70,878 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:27 UTC |
Lloyd Brian G.Chief Legal Officer, Secretary
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003699 · edgar.xml · derivative · entry 4 Lloyd Brian G. · CIK 0001671772 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-03-02 F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:25 UTC |
Lampropoulos Justin J.EXEC. V.P. MKTG & STRATEGY
|
GrantNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003698 · edgar.xml · derivative · entry 7 Lampropoulos Justin J. · CIK 0001643609 · EXEC. V.P. MKTG & STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-03-02 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:23 UTC |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003695 · edgar.xml · derivative · entry 14 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to Footnote Number five. Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-03-02 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. F5 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:23 UTC |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 38,002 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003695 · edgar.xml · derivative · entry 13 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,002 Underlying: Common Stock · 38,002 shares Expires 2025-03-02 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:19 UTC |
Frost RonaldChief Operating Officer
|
GrantNon-qualified stock options (right to buy) · Derivative | 40,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003690 · edgar.xml · derivative · entry 7 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2025-03-02 F7 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 03/02/2019. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:17 UTC |
Birkett BernardChief Financial Officer
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003689 · edgar.xml · derivative · entry 7 Birkett Bernard · CIK 0001658001 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-03-02 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/02/19. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:14 UTC |
Wright JosephPresident, International
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003687 · edgar.xml · derivative · entry 7 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-03-02 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 20:44 UTC |
Miller Franklin JDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-000074 · edgar.xml · derivative · entry 4 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 20:44 UTC |
Miller Franklin JDirector
|
SaleCommon Stock, No Par Value | 10,000 | $43.93 | $439,250.00 |
DisclosureSEC source: 0001179110-18-000074 · edgar.xml · nonDerivative · entry 3 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,244 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.85 to $44.00, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 20:44 UTC |
Miller Franklin JDirector
|
Exercise / conversionCommon Stock, No Par Value | 10,000 | $13.75 | $137,500.00 |
DisclosureSEC source: 0001179110-18-000074 · edgar.xml · nonDerivative · entry 2 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2017 Filed Feb 13, 2018 20:12 UTC |
STANGER KENT WDirector
|
GiftCommon Stock, No Par Value | 550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-001996 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,984 F4 · price: This is a gift. Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 00:36 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 9,082 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-015679 · edgar.xml · derivative · entry 6 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 9,082 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 00:36 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 9,082 | $44.90 | $407,781.80 |
DisclosureSEC source: 0001179110-17-015679 · edgar.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.50 to $45.35, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 00:36 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 9,082 | $13.75 | $124,877.50 |
DisclosureSEC source: 0001179110-17-015679 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.